1. Canine Mammary Tumor Cell Lines Derived from Metastatic Foci Show Increased RAD51 Expression but Diminished Radioresistance via p21 Inhibition
    Kei Shimakawa et al, 2022, Veterinary Sciences CrossRef
  2. Review: The PI3K-AKT-mTOR signal transduction pathway in canine cancer
    Travis K. Meuten et al, 2024, Veterinary Pathology CrossRef
  3. Anticancer effects of alpelisib on PIK3CA-mutated canine mammary tumor cell lines
    Jiah Yeom et al, 2023, Frontiers in Veterinary Science CrossRef
  4. Molecular Profile of Canine Hemangiosarcoma and Potential Novel Therapeutic Targets
    Pedro Antônio Bronhara Pimentel et al, 2023, Veterinary Sciences CrossRef
  5. Establishment of a BRAF V595E‐mutant canine prostate cancer cell line and the antitumor effects of MEK inhibitors against canine prostate cancer
    Masanori Kobayashi et al, 2023, Veterinary and Comparative Oncology CrossRef
  6. Synergistic actions of Alpelisib and Melatonin in breast cancer cell lines with PIK3CA gene mutation
    Bianca Lara Venâncio de Godoy et al, 2023, Life Sciences CrossRef
  7. New molecular targets in canine hemangiosarcoma—Comparative review and future of the precision medicine
    Karolina Małgorzata Kapturska et al, 2023, Veterinary and Comparative Oncology CrossRef
  8. Role of protein phosphorylation in cell signaling, disease, and the intervention therapy
    Kun Pang et al, 2022, MedComm CrossRef
  9. Clinical Use of Molecular Biomarkers in Canine and Feline Oncology: Current and Future
    Heike Aupperle-Lellbach et al, 2024, Veterinary Sciences CrossRef
  10. Current understanding of comparative pathology and prospective research approaches for canine hemangiosarcoma
    Tamami Suzuki et al, 2024, Research in Veterinary Science CrossRef